Daniel Smith, MD
NPI 1023081130 · Specialist · Asheville, NC
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Daniel Smith, MD is a Specialist provider in Asheville, NC (NPI 1023081130).
Provider details
- NPI number
- 1023081130
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 9500451 (NC)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
5,652 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,706 | $86 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,283 | $6 |
| Biopsy of Related Skin Growth, First Growth11102 | 752 | $87 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 613 | $46 |
| Destruction of Skin Growth, 1-14 Growths17110 | 244 | $102 |
| Biopsy of Related Skin Growth, Each Additional Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 173 | 117 |
| Hydrocortisone | 110 | 90 |
| Doxycycline Hyclate | 106 | 45 |
| Mupirocin | 103 | 68 |
| Clobetasol Propionate | 73 | 51 |
| Metronidazole | 59 | 33 |
| Ketoconazole | 48 | 40 |
| Fluorouracil | 39 | 34 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$384 across 17 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-02-09
- Last updated
- 2019-09-03
Frequently asked questions
- What is Daniel Smith's NPI number?
- Daniel Smith's National Provider Identifier (NPI) is 1023081130, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Daniel Smith's specialty?
- Daniel Smith is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Daniel Smith located?
- Daniel Smith's practice location on file with NPPES is 281 Mcdowell St, Asheville, NC 28803-2606.
- What is Daniel Smith's phone number?
- The practice phone number listed in the NPPES registry for Daniel Smith is (828) 252-5676.
- Does Daniel Smith accept Medicare?
- Daniel Smith is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Daniel Smith's NPI active?
- Yes — Daniel Smith's NPI (1023081130) is active in the NPPES registry as of the last update on 2019-09-03.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.